


Cinerea Biotech is a reputed PCD Pharma Franchise Company in India, offering an extensive general pharmaceutical range for entrepreneurs, distributors, and healthcare professionals across the country. With more than 25 years of experience in the pharmaceutical industry, the company has developed a strong presence through quality products, reliable services, and monopoly-based franchise opportunities.
The company offers 500+ pharmaceutical products across multiple therapeutic segments, including analgesics, antibiotics, anti-allergics, muscle relaxants, critical care, nutritional supplements, gastrointestinal products, hematinics, dermatology, pediatric, and Ayurvedic formulations. Its products are available in different dosage forms such as tablets, capsules, softgel capsules, injections, syrups, suspensions, powders, dry syrups, drops, creams, ointments, and external preparations.
Cinerea Biotech provides state-wise and district-wise monopoly PCD Pharma Franchise opportunities, helping franchise partners establish their pharmaceutical businesses with dedicated territory rights. The company also supports its partners with promotional materials, marketing assistance, attractive product packaging, competitive pricing, and timely product delivery.
With an experienced team, ISO 9001:2015 certification, WHO-GMP/CGMP manufacturing standards, and a growing network of pharma partners, Cinerea Biotech continues to strengthen its position as a reliable choice for entrepreneurs looking for the Best PCD Pharma Franchise for General Range in India.
Cinerea Biotech follows ISO-certified quality systems and WHO-GMP/CGMP manufacturing standards, with rigorous product testing to maintain safety, quality, consistency, and regulatory compliance.
To provide high-quality, affordable pharmaceutical medicines through innovation, responsible practices, and reliable services while creating sustainable value for healthcare partners.
To become a leading pharmaceutical company in India by delivering excellence in product quality, service, innovation, and long-term commitment to healthcare.
N/A